IL6 and heart failure: This meta-analysis provides comprehensive evidence that elevated systemic inflammatory biomarkers—especially interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and the neutrophil-to-lymphocyte ratio (NLR)—are significant independent predictors of mortality and adverse outcomes in heart failure (HF).